ZVRA Q1 2020 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ZVRAZevra Therapeutics, Inc.

$559M

Q1 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

$1M68.3% margin

Operating Income

-$4M-180.7% margin

Net Income

-$6M-275.4% margin

EPS (Diluted)

$-1.92

QoQ Revenue Growth

+51.8%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$9M

Total Liabilities

$78M

Stockholders' Equity

-$69M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$4M	-$11M	+66.8%
Net Income	-$6M	-$12M	+53.2%